Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
David Teachey, MD, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, discusses the role of genomic characterization in T-cell acute lymphoblastic leukemia (T-ALL) both at diagnosis and at relapse. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.